logo
AAT Bioquest

Nuclear receptor subfamily 1 group I member 3 Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
ClotrimazoleIC5080.0 [1], 100.0 [2], 690.0 [3]
ClotrimazoleKi100.0 [1]
Ethinyl estradiolIC503000.0 [1]
1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamideIC50390.0 [1]
TiracizineIC504078.0 [1]
AndrostanolIC501200.0 [1]
Propan-2-yl N-[11-[3-(diethylamino)propanoyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC506400.0 [1]
Ethyl 5-(N,N-dimethyl-beta-alanyl)-10,11-dihydro-5H-dibenzo[b,f]azepin-3-ylcarbamateIC505010.0 [1]
Ethyl N-[11-[3-(diethylamino)propanoyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC502430.0 [1]
Carbamic acid, (5-((ethylamino)acetyl)-10,11-dihydro-5H-dibenz(b,f)azepin-3-yl)-, ethyl esterIC5024490.0 [1]
Carbamic acid, (5-(aminoacetyl)-10,11-dihydro-5H-dibenz(b,f)azepin-3-yl)-, ethyl esterIC5070000.0 [1]
Cinpa1IC50687.0 [1]
CID 1069342IC50235.0 [1]
Ethyl N-[11-(3-morpholin-4-ylpropanoyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC50320.0 [1]
Ethyl N-[11-[2-(4-methylpiperazin-1-yl)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5038755.0 [1]
Ethyl N-[11-[2-(dipropylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC50210.0 [1]
Propan-2-yl N-[11-(2-piperidin-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC50249.0 [1]
Propan-2-yl N-[11-[2-(diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC50680.0 [1]
CID 1129891IC50620.0 [1]
Propan-2-yl N-[11-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propanoyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5070000.0 [1]
Methyl N-[11-(3-morpholin-4-ylpropanoyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC50288.0 [1]
Ethyl N-[11-[2-(2,2,6,6-tetramethylpiperidin-1-yl)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC504080.0 [1]
Ethyl N-[11-[2-(7-azabicyclo[2.2.1]heptan-7-yl)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC501410.0 [1]
Ethyl N-[11-[2-(2,5-dioxopyrrol-1-yl)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5039810.0 [1]
Propan-2-yl N-[11-[2-(2,2-dimethylpropoxy)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5021.2 [1]
Tert-butyl N-[11-[2-(dipropylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC50152.9 [1]
Tert-butyl N-[11-(2-piperidin-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC50216.2 [1]
Tert-butyl N-[11-(2-propan-2-yloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC50116.0 [1]
Cyclohexyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5011.7 [1]
Propan-2-yl N-[11-(2-cyclopropyloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5081.5 [1]
Propan-2-yl N-[11-(2-cyclobutyloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5037.6 [1]
Propan-2-yl N-[11-(2-cyclopentyloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5019.5 [1]
Propan-2-yl N-[11-(2-cyclohexyloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5024.1 [1]
Tert-butyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5031.9 [1]
Cyclopropyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5022.1 [1]
Cyclobutyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5020.1 [1]
Cyclopentyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5013.9 [1]
Ethyl N-[11-(3-pyrrolidin-1-ylpropanoyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC503180.0 [1]
Ethyl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5037.0 [1]
Ethyl N-[11-[2-(2-methylbutan-2-ylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC502060.0 [1]
Ethyl N-[11-[2-[(2-methylpropan-2-yl)oxy]acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5070.8 [1]
N-[11-[2-(Diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]butanamideIC502320.0 [1]
Tert-butyl N-[11-[2-(diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC501030.0 [1]
1-[11-[2-(Diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]-3-ethylureaIC5014420.0 [1]
1-[11-[2-(Diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]-3-propan-2-ylureaIC504930.0 [1]
1-Tert-butyl-3-[11-[2-(diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]ureaIC5012970.0 [1]
Ethyl N-[11-(2-imidazol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC506890.0 [1]
3-[11-[2-(Diethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]-1,1-diethylureaIC5013990.0 [1]
2-(Diethylamino)-1-[2-(ethylsulfamoylamino)-5,6-dihydrobenzo[b][1]benzazepin-11-yl]ethanoneIC5019090.0 [1]
2-(Diethylamino)-1-[2-[(5-methyl-1,3,4-oxadiazol-2-yl)amino]-5,6-dihydrobenzo[b][1]benzazepin-11-yl]ethanoneIC5018790.0 [1]
Propan-2-yl N-[11-[2-(dipropylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC50116.4 [1]
Propan-2-yl N-[11-(2-pyrrol-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5020.9 [1]
Propan-2-yl N-[11-(2-ethoxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5011350.0 [1]
Propan-2-yl N-[11-(2-propan-2-yloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5060.1 [1]
Propan-2-yl N-[11-(2-butan-2-yloxyacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC5035.3 [1]
Ethyl N-[11-[2-[di(propan-2-yl)amino]acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC503050.0 [1]
Ethyl N-[11-(2-pyrrolidin-1-ylacetyl)-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC501580.0 [1]
Ethyl N-[11-[2-(tert-butylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC503631.0 [1]
Propan-2-yl N-[11-[3-(dimethylamino)propanoyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamateIC501792.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Nuclear receptor subfamily 1 group I member 3 Inhibitors (IC50, Ki)." AAT Bioquest, Inc.21 Dec2024https://www.aatbio.com/data-sets/nuclear-receptor-subfamily-1-group-i-member-3-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024December 21). Quest Database™ Nuclear receptor subfamily 1 group I member 3 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/nuclear-receptor-subfamily-1-group-i-member-3-inhibitors-ic50-ki.
BibTeXEndNoteRefMan